Disparities in the enrollment to systemic therapy and survival for patients with multiple myeloma ☆ | Zendy

Thejus Jayakrishnan | Zendy; Veli Bakalov | Zendy; Zena Chahine | Zendy; John Lister | Zendy; Rodney E. Wegner | Zendy; Santhosh Sadashiv | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Disparities in the enrollment to systemic therapy and survival for patients with multiple myeloma ☆

Author(s) -

Thejus Jayakrishnan,

Veli Bakalov,

Zena Chahine,

John Lister,

Rodney E. Wegner,

Santhosh Sadashiv

Publication year - 2020

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2020.09.005

Subject(s) - medicine , proportional hazards model , multivariate analysis , socioeconomic status , poisson regression , demography , hazard ratio , survival analysis , systemic therapy , comorbidity , multivariate statistics , cancer , oncology , gerontology , population , environmental health , confidence interval , breast cancer , statistics , mathematics , sociology

Disparities driven by socioeconomic factors have been shown to impact outcomes for cancer patients. We sought to explore this relationship among patients with multiple myeloma (MM) who were not considered for hematopoietic stem cell transplant in the first-line setting and how it varied over time.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research